Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP)
announced today that on March 26, 2019, the Fifth Circuit Court of
Appeals affirmed the district court's finding which had determined that
neither disgorgement of profits nor further injunctive relief should be
granted to Retractable in its case against Becton, Dickinson and Company
("BD"), despite finding that BD falsely advertised its products for
years. Retractable is evaluating this ruling and conferring with legal
counsel regarding possible future action.
Retractable manufactures and markets VanishPoint® and Patient
Safe® safety medical products and the EasyPoint®
needle. The VanishPoint® syringe, blood collection, and IV
catheter products are designed to prevent needlestick injuries and
product reuse by retracting the needle directly from the patient,
effectively reducing exposure to the contaminated needle. Patient Safe®
syringes are uniquely designed to reduce the risk of bloodstream
infections resulting from catheter hub contamination. The EasyPoint®
is a retractable needle that can be used with luer lock syringes, luer
slip syringes, and prefilled syringes to give injections. The EasyPoint®
needle also can be used to aspirate fluids and for blood collection.
Retractable's products are distributed by various specialty and general
For more information on Retractable, visit its website at www.retractable.com.
Forward-looking statements in this press release are made pursuant to
the safe harbor provision of the Private Securities Litigation Reform
Act of 1995 and reflect Retractable's current views with respect to
future events. Retractable believes that the expectations reflected in
such forward-looking statements are accurate. However, Retractable
cannot assure you that such expectations will materialize. Actual future
performance could differ materially from such statements.
Factors that could cause or contribute to such differences include, but
are not limited to: potential tariffs, Retractable's ability to maintain
liquidity; Retractable's maintenance of patent protection; the impact of
current and future Court decisions regarding current litigation;
Retractable's ability to maintain favorable third party manufacturing
and supplier arrangements and relationships; foreign trade risk;
Retractable's ability to quickly increase capacity in response to an
increase in demand; Retractable's ability to access the market;
Retractable's ability to maintain or lower production costs;
Retractable's ability to continue to finance research and development as
well as operations and expansion of production; the impact of larger
market players, specifically BD, in providing devices to the safety
market; and other risks and uncertainties that are detailed from time to
time in Retractable's periodic reports filed with the U.S. Securities
and Exchange Commission.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190327005523/en/
Retractable Technologies, Inc.
Michele M. Larios, 888-806-2626 or
Vice President, General Counsel, and Secretary